CLINICAL_TRIALS
trial_result
· 2025-11-10
Clinical Trial Update: Neoadjuvant Chemoradiation for Resectable Glioblastoma [Phase 2]
Summary
A Phase 2 trial evaluating neoadjuvant chemoradiation for resectable glioblastoma was terminated, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Geisinger Clinic | Conditions: Glioblastoma, Surgery | Phase 2 | Status: TERMINATED | Results posted: 2025-11-10